‘Text/HTML’ of page ‘NRG-GU012: Radiation and Immune Therapy for Renal Cell Cancer’
Frequently Asked Questions Below, you can find FAQs about clinical research and this particular clinical trial.
Read MoreContent Block Tag: NRG-GU012: Radiation and Immune Therapy for Renal Cell Cancer
‘Text/HTML’ of page ‘NRG-GU012: Radiation and Immune Therapy for Renal Cell Cancer’
Am I eligible for this study? If you over the age of 18 with renal cell cancer that has spread beyond your kidney and surgery is not currently recommended OR you have chosen not to have surgery, you may be able to participate. Your healthcare team is the best source for information about your treatment options, including cancer clinical […]
Read More‘Text/HTML’ of page ‘NRG-GU012: Radiation and Immune Therapy for Renal Cell Cancer’
About This Study NRG-GU012, also known as “the SAMURAI study”, is a clinical study for people with renal cell cancer that has spread beyond the kidneys, also known as metastatic renal cell cancer. This trial is specifically for patients who are not planning on receiving surgery for their disease, or for patients not recommended […]
Read More‘Text/HTML’ of page ‘NRG-GU012: Radiation and Immune Therapy for Renal Cell Cancer’
Clinical Studies FAQ
Read More‘Text/HTML’ of page ‘NRG-GU012: Radiation and Immune Therapy for Renal Cell Cancer’
The SAMURAI Study FAQ
Read More